ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XNCR vs IMNM // FREE CASH FLOW YIELD

Xencor Inc. (NASDAQ) VS. Immunome Inc. (NASDAQ) • 15-METRIC TALLY: XNCR 6 — IMNM 1
▲ FREE CASH FLOW YIELD LEADER: XNCR
fcf-yield
-6.37%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XNCR VS. IMNM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XNCR IMNM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -21.30% -35.00% +13.70 XNCR /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -6.37% -9.29% +2.92 XNCR /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 13.70% -23.20% +36.90 XNCR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.32 25.03 -20.71 IMNM /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 XNCR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 64.2 40.2 +24.00 XNCR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.17B $2.16B $13.6M XNCR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XNCR REV IMNM REV XNCR GROSS % IMNM GROSS % XNCR FCF IMNM FCF
FY 2025 $125.6M $6.9M — — -$138.3M -$200.6M
FY 2024 $110.5M $9.0M — — -$208.3M -$118.0M
FY 2023 $174.6M $14.0M — — -$77.9M -$7.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XNCR // BETA —
IMNM // BETA —